This Investment Research Paper addresses the issue of renewable power generation in the UK and in mainland Europe, which – after the deep-seated financial crisis of 2008/09 and the ensuing recession – now has better prospects of achieving critical mass. It also considers investment perspectives.

05 Feb 2019
THE MONTHLY February 2019
Time Finance plc (TIME:LON), 55.0 | AJ Bell Plc (AJB:LON), 540 | Allergy Therapeutics plc (AGY:LON), 7.9 | Arbuthnot Banking Group PLC (ARBB:LON), 1,020 | Avacta Group PLC (AVCT:LON), 51.5 | Amala Foods Plc (DISH:LON), 0.1 | Burford Capital Limited (BUR:LON), 962 | City of London Investment Group PLC (CLIG:LON), 359 | DP Poland PLC (DPP:LON), 10.2 | Gateley (Holdings) Plc (GTLY:LON), 123 | Genedrive Plc (GDR:LON), 1.2 | Haydale Graphene Industries Plc (HAYD:LON), 0.7 | Koovs (KOOV:LON), 0 | Murgitroyd Group (MUR:LON), 0 | Oxford BioMedica plc (OXB:LON), 456 | Palace Capital plc (PCA:LON), 226 | R.E.A. Holdings plc (RE:LON), 90.5 | Shield Therapeutics Plc (STX:LON), 4.6 | Surface Transforms PLC (SCE:LON), 1.3 | Tissue Regenix Group plc (TRX:LON), 35.5 | Titon Holdings Plc (TON:LON), 90.0 | Volta Finance Limited (VTA:LON), 690 | Warpaint London PLC (W7L:LON), 362 | ValiRx PLC (VAL:LON), 0.6

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
THE MONTHLY February 2019
Time Finance plc (TIME:LON), 55.0 | AJ Bell Plc (AJB:LON), 540 | Allergy Therapeutics plc (AGY:LON), 7.9 | Arbuthnot Banking Group PLC (ARBB:LON), 1,020 | Avacta Group PLC (AVCT:LON), 51.5 | Amala Foods Plc (DISH:LON), 0.1 | Burford Capital Limited (BUR:LON), 962 | City of London Investment Group PLC (CLIG:LON), 359 | DP Poland PLC (DPP:LON), 10.2 | Gateley (Holdings) Plc (GTLY:LON), 123 | Genedrive Plc (GDR:LON), 1.2 | Haydale Graphene Industries Plc (HAYD:LON), 0.7 | Koovs (KOOV:LON), 0 | Murgitroyd Group (MUR:LON), 0 | Oxford BioMedica plc (OXB:LON), 456 | Palace Capital plc (PCA:LON), 226 | R.E.A. Holdings plc (RE:LON), 90.5 | Shield Therapeutics Plc (STX:LON), 4.6 | Surface Transforms PLC (SCE:LON), 1.3 | Tissue Regenix Group plc (TRX:LON), 35.5 | Titon Holdings Plc (TON:LON), 90.0 | Volta Finance Limited (VTA:LON), 690 | Warpaint London PLC (W7L:LON), 362 | ValiRx PLC (VAL:LON), 0.6
- Published:
05 Feb 2019 -
Author:
Hardman & Co Research Team -
Pages:
48 -
This Investment Research Paper addresses the issue of renewable power generation in the UK and in mainland Europe, which – after the deep-seated financial crisis of 2008/09 and the ensuing recession – now has better prospects of achieving critical mass. It also considers investment perspectives.